How many companies City of St. Louis received FDA citations in 2024?

How many companies City of St. Louis received FDA citations in 2024?
Jim Jones Deputy Commissioner for Human Foods of FDA — Official Website
0Comments

There were 11 companies in the City of St. Louis that received FDA citations as a result of 11 inspections conducted in the city throughout 2024, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 57.1% increase over the number of companies cited in the previous year.

Of the 48 citations issued, the most common citation was ‘Procedures for corrective and preventive action have not been adequately established’.

Most of the companies cited were involved in the Devices sector. The second most common type of company cited in the time period worked in the Drugs sector.

All of the companies cited should take voluntary actions to correct their managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

Companies Located Within City of St. Louis and the Citations They Received in 2024
Company Name Area of Business Inspection Date Issue Cited
Allied Medical, LLC Devices 10/30/2024 Report of Death or Serious Injury
Allied Medical, LLC Devices 10/30/2024 Purchasing controls, Lack of or inadequate procedures
Allied Medical, LLC Devices 10/30/2024 Contamination control, Lack of or inadequate procedures
Allied Medical, LLC Devices 10/30/2024 Lack of or inadequate process validation
Allied Medical, LLC Devices 10/30/2024 Lack of or inadequate procedures
Apolo – Megasun, LLC Devices 08/29/2024 Label to bear a unique device identifier
Apolo – Megasun, LLC Devices 08/29/2024 Design control – no procedures
Apolo – Megasun, LLC Devices 08/29/2024 Calibration, Inspection, etc. Procedures Lack of or Inadequ
Apolo – Megasun, LLC Devices 08/29/2024 Lack of or inadequate final acceptance procedures
Brian Van Tine Drugs 01/26/2024 FD-1572, protocol compliance
Center for Reproductive Medicine & Robotic Surgery, LLC Biologics 03/11/2024 Risk factors, clinical evidence
Center for Reproductive Medicine & Robotic Surgery, LLC Biologics 03/11/2024 SOP for release; reactive for CMV
Matthew A. Powell, M.D. Drugs 06/03/2024 Safety Reports – Non-Serious Events
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Control procedures to monitor and validate performance
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Procedures for sterile drug products
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Scientifically sound laboratory controls
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Acceptance criteria for sampling & testing
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Investigations of discrepancies, failures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Design output – Lack of or inadequate procedures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Design validation – Risk analysis
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Purchasing controls, Lack of or inadequate procedures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Devices 06/05/2024 Lack of or inadequate procedures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Control procedures to monitor and validate performance
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Procedures for sterile drug products
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Scientifically sound laboratory controls
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Acceptance criteria for sampling & testing
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Investigations of discrepancies, failures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Design output – Lack of or inadequate procedures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Design validation – Risk analysis
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Purchasing controls, Lack of or inadequate procedures
Meridian Medical Technologies a Subsidiary of Kindeva Drug Delivery, L. P., LLC Drugs 06/05/2024 Lack of or inadequate procedures
Mid-America Transplant Services Biologics 08/23/2024 Process validation procedures
Ohlendorf Company Devices 06/26/2024 Label to bear a unique device identifier
Ohlendorf Company Devices 06/26/2024 Lack of or inadequate organizational structure
Ohlendorf Company Devices 06/26/2024 Devices subject to device identification GUDID data submission requirements.
Radialogica, LLC Devices 03/06/2024 Design review – Lack of or inadequate procedures
Radialogica, LLC Devices 03/06/2024 Lack of or inadequate procedures
Radialogica, LLC Devices 03/06/2024 Complaints
Sentiar, Inc. Devices 03/21/2024 Management review – Lack of or inadequate procedures
Sentiar, Inc. Devices 03/21/2024 Quality audits – Lack of or inadequate procedures
Sentiar, Inc. Devices 03/21/2024 Evaluation and Selection, Suppliers, Contractors, etc.
Sentiar, Inc. Devices 03/21/2024 Lack of or inadequate DHR procedures
Sentiar, Inc. Devices 03/21/2024 Complaints
Sentiar, Inc. Devices 03/21/2024 GUDID Information required for unique device identification.
Wan-Gee Foods, Inc. Food and Cosmetics 05/10/2024 Personnel
Wan-Gee Foods, Inc. Food and Cosmetics 05/10/2024 Manufacturing, processing, packing, holding – Controls
Wan-Gee Foods, Inc. Food and Cosmetics 05/10/2024 Process preventive controls – Implement
Wan-Gee Foods, Inc. Food and Cosmetics 05/10/2024 Process preventive controls – Appropriate (Adequate)


Related

Dr. Mehmet Oz CMS Administrator

Rosewood Rehab and Healthcare Center supported 246 daily residents as Jackson County’s No. 2 largest nursing home in Q1 2026

During the first quarter of 2026, Rosewood Rehab and Healthcare Center served an average of 245.6 residents per day, making it the second largest nursing home in Jackson County.

14855 N Outer 40 Road, Chesterfield, MO 63017

Ownership and CMS rating of Delmar Gardens of Chesterfield in Q1

Delmar Gardens of Chesterfield, under Delmar Gardens Enterprises, Inc. since Feb. 18, 2005, received an overall CMS rating of 3 during the first quarter of 2026.

Dr. Oz serves as the 17th Administrator for the Centers for Medicare u0026 Medicaid Services

NHC Healthcare, Desloge identified as No. 2 nursing home in St. Francois County for Q1 2026

With an overall 4-star CMS rating, NHC Healthcare, Desloge ranked as the second largest nursing home in St. Francois County during Q1 2026.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from St. Louis Reporter.